CombImmune

CombImmune is a medical oncology and diagnostics company dedicated to designing and marketing novel immunotherapies and diagnostic tools for the oncology and hematology markets. CombImmune's mission is to leverage prognostic and predictive biomarkers, combined with therapeutics, to restore immune function, disrupt tumors, and reveal tumor-infiltrating immune dysfunction, focusing on developing intelligently designed cancer treatment regimens and diagnostics through a combinatorial approach.